News | August 09, 2023
Hikal posts Q1 FY 24 consolidated PAT at Rs. 6.92 Cr
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
KIMS has reported total income of Rs. 609.14 crores during the period ended June 30, 2023
Torrent Pharmaceuticals has reported total income of Rs. 2625 crores during the period ended June 30, 2023
Gland Pharma has reported total income of Rs. 1246.23 crores during the period ended June 30, 2023
The company has reported total income of Rs. 115.37 crores during the period ended June 30, 2023
Fortis Healthcare has reported total income of Rs. 1665.55 crores during the period ended June 30, 2023
The company has reported total income of Rs. 310.07 crores during the period ended June 30, 2023
Merck continues progress in helping to protect people at risk of Zaire ebolavirus disease
The inspection was conducted at Granules Pharmaceuticals Inc. (GPI) from July 31, 2023 to August 03, 2023
The company has reported total income of Rs. 704.5 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated
